[144] Dolby Laboratories, Inc. SEC Filing

Rhea-AI Filing Summary

Dolby Laboratories (DLB) insider filing reports planned sale of 25,000 shares of common stock with an aggregate market value of $1,850,530. The securities were acquired through a stock option exercise on June 24, 2025, and are planned to be sold through Morgan Stanley Smith Barney LLC on the NYSE.

The filing also discloses recent trading activity by the Yeaman Family Trust, which sold:

• 25,000 shares for gross proceeds of $1,905,650 on June 10, 2025
• 8,683 shares for gross proceeds of $661,829 on June 10, 2025

This Form 144 represents a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. The total shares to be sold represent approximately 0.026% of Dolby's outstanding shares (96,066,188 shares).

Positive

• None.

Negative

• Insider selling pattern: Multiple sales by the Yeaman Family Trust totaling 33,683 shares worth approximately $2.57M in June 2025, followed by another planned sale of 25,000 shares worth $1.85M
• The aggregate insider sales within a short period (approximately $4.42M total) could signal reduced confidence in near-term stock performance

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	1850530.00	96066188	06/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/24/2025	Stock Option Exercise	ISSUER			25000	06/24/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	06/10/2025	25000	1905650.00
YEAMAN FAMILY TRUST U/A DTD 05/14/2009 1275 Market Street San Francisco CA 94103-1410	Common	06/10/2025	8683	661828.68

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many DLB shares are being sold according to the June 2025 Form 144 filing?

According to the Form 144 filing, 25,000 shares of DLB common stock are proposed to be sold through Morgan Stanley Smith Barney LLC at an aggregate market value of $1,850,530.00.

What was the recent trading activity by the Yeaman Family Trust for DLB stock?

The Yeaman Family Trust made two sales of DLB stock on June 10, 2025: one sale of 25,000 shares for gross proceeds of $1,905,650.00, and another sale of 8,683 shares for gross proceeds of $661,828.68.

How were the DLB shares acquired that are being sold in this Form 144?

The shares were acquired through a Stock Option Exercise from the issuer (Dolby Laboratories) on June 24, 2025, with payment made in cash on the same date for 25,000 shares.

What is the total number of outstanding DLB shares according to the Form 144?

According to the Form 144 filing, Dolby Laboratories (DLB) has 96,066,188 shares outstanding.

When is the approximate date of sale for the DLB shares in this Form 144?

The approximate date of sale for the DLB shares is indicated as June 24, 2025, to be executed on the NYSE (New York Stock Exchange).